A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1-4, as a single dose and multiple doses in patients with solid malignancies
- Issued Date
- 2020
- Type
- Article
- Publisher
- INVESTIGATIONAL NEW DRUGS
- Language
- 영어
- ISSN
- 0167-6997
- Citation Volume
- 38
- Citation Number
- 2
- Citation Start Page
- 445
- Citation End Page
- 456
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.